Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ardena has launched Ardena LSI, a new arm of its business dedicated to the sale of chemical ingredients and intermediates for the life science industry.
read more
Monday, September 11, 2017
A new early-phase contract development and manufacturing organization, Ardena, has launched following the merging of Pharmavize and Crystallics.
read more
Wednesday, April 15, 2026
Ardena announced that its new GLP bioanalytical laboratory in Somerset, New Jersey, is now operational and supporting client studies.
read more
Ardena announced the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and ...
read more
Ardena announced it has signed a definitive agreement to acquire Catalent’s state-of-the-art facility in Somerset, NJ.
read more
Wednesday, November 29, 2023
Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has been granted a Good Manufacturing Practice (GMP) license by the Belgian Federal Agency for Medicines and Health Products (...
read more
Tuesday, November 19, 2024
Ardena announced the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, Netherlands.
read more
Thursday, January 02, 2020
Arena Pharmaceuticals and Beacon Discovery have entered into a strategic multi-year partnership aimed at building novel medicines across a range of GPCR targets.
read more
Tuesday, December 05, 2017
Arena Pharmaceuticals and Everest Medicines Limited have entered into a development and commercialization partnership for ralinepag and etrasimod in the Territories.
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, January 16, 2020
Argonaut Manufacturing Services has announced the recent launch of their state-of-the-art aseptic vial filling services.
read more
Thursday, January 12, 2023
Argonaut Manufacturing Services announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.
read more
Argonaut Manufacturing Services announced the completion of a $45 million financing to support its new drug product fill/finish expansion. This expansion in Carlsbad, CA, underway since early 2023, includes a new dedicated facility with a state-of-...
read more
Thursday, November 06, 2025
Argonaut Manufacturing Services announced the appointment of Rick Hancock as Chief Executive Officer (CEO).
read more
Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving the biopharmaceutical and diagnostics ...
read more